检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:姚华[1] 林德贵[1] 乔富强[2] 田克恭[3] 遇秀玲[3] 胡冬梅[3]
机构地区:[1]中国农业大学动物医学院,北京100094 [2]北京农学院科技产业集团,北京102206 [3]农业部兽医诊断中心,北京100094
出 处:《中国农业大学学报》2006年第3期31-35,共5页Journal of China Agricultural University
基 金:国家自然科学基金资助项目(30471275)
摘 要:为便于确定肿瘤的组织学来源,推测其在兽医临床诊断中的鉴别意义,研究p63和Calponin蛋白在20例犬乳腺肿瘤(canine mammary tumor,CMT)病例中的表达,采用免疫组织化学(immunohistochemistry,IHC)SP染色方法和光学显微镜观察进行确诊。结果表明,鼠抗人单克隆抗体p63和Calponin可用于犬乳腺肿瘤病例中肌上皮的表达研究,在乳头状瘤、混合瘤及腺肌上皮瘤等犬良性乳腺肿瘤组织中p63与Calponin表达为阳性或强阳性;在乳头状癌、浸润性导管癌等恶性肿瘤组织中p63与Calponin蛋白表现为阴性或局灶阳性。选择p63与Calponin作为犬乳腺肿瘤组织基底和腺肌上皮细胞的标记物有一定的敏感性和特异性,对良、恶性乳腺肿瘤组织、乳腺肿瘤或癌旁组织的来源和临床诊断等具有鉴别和指导作用。In order to confirm the histological source of the tumor tissue and presume the significance in differential diagnosis, 20 cases of canine mammary tumor were used to investigate the expression of p63 and Calponin proteins by immunohistochemical SP method and observed by the light microscope. Results showed that the monoclonal mouse antihuman p63 and Calponin antibodies could be used to evaluate the expression of myoepithelial cells in canine mammary tumor. In benign mammary tumors, such as the papillary tumor, mixed tumor and adenomyoepithelioma, the myoepithelial cells were showed strong immureactivities with the p63 and Calponin proteins, and unimmureactivities or partially immureactivities with them in malignant tumor tissues of the papillary carcinoma and infiltrating ductal carcinoma. The two antibodies of p63 and Calponin were proved that they presented an excellent sensitivity and specificity for basal and myoepithelial cell being markers. They formed a good tool in clinical diagnosis and in processing the histological resources of the benign and malignant mammary tumor tissues, the tumor and the tissue around the carcinoma.
关 键 词:犬乳腺肿瘤(CMT) P63 CALPONIN 免疫组织化学(IHC)
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222